Moderna likely to report late-stage Covid-19 vaccine data in November
Moderna says it is preparing to distribute the vaccine, and expects to be able to produce 20-million doses by the end of 2020
29 October 2020 - 17:46
Moderna said on Thursday it was on track to report early data from a late-stage trial of its experimental Covid-19 vaccine in November, offering the clearest timeline yet for when the world will know whether it is effective.
The company, one of the front-runners in the global race to produce vaccines to protect against Covid-19, said an independent data monitoring committee was expected to conduct an interim review of its ongoing 30,000-person trial in November. Its shares rose 3%...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.